Clindamycin 600 mg IV every 6 to 8 hours was the drug of choice because it has excellent activity against streptococci and anaerobic organisms; however, it has become a second-line drug because of concern for the substantial rate of Clostridioides (formerly, Clostridium) difficile infection if clindamycin therapy is prolonged.